Chicago Trust CO Na Regeneron Pharmaceuticals, Inc. Transaction History

Chicago Trust CO Na

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$595.12 - $698.43 $641,539 - $752,907	-1,078 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$574.03 - $680.96 $54,532 - $64,691	95 Added 9.66%	1,078 $652,000
Q2 2021 Jul 21, 2021	BUY	$472.8 - $558.54 $464,762 - $549,044	983 New	983 $549,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Chicago Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Chicago Trust CO Na with notifications on news.